Novel CAR T-cell therapy for leukaemia and lymphoma
Scientists in the US have developed a promising new CAR…
Scientists in the US have developed a promising new CAR T-cell therapy that targets the BAFF-R protein, which has demonstrated superior cancer destruction to existing FDA-approved CAR-T therapies.